View in EDS

Efficacy of osimertinib against EGFRvIII+ glioblastoma.

Saved in:
Bibliographic Details
Title: Efficacy of osimertinib against EGFRvIII+ glioblastoma.
Authors: Chagoya G; Department of Neurosurgery, The University of Alabama at Birmingham, Birmingham, AL, USA., Kwatra SG; Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Nanni CW; Departments of Anesthesiology, Duke University Medical Center, Durham, NC, USA., Roberts CM; Departments of Anesthesiology, Duke University Medical Center, Durham, NC, USA., Phillips SM; Tri-Institutional MD-PhD Program, Weill Cornell Medical College, The Rockefeller University, Memorial Sloan Kettering Cancer Institute, New York, NY, USA., Nullmeyergh S; Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA., Gilmore SP; Departments of Anesthesiology, Duke University Medical Center, Durham, NC, USA., Spasojevic I; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA., Corcoran DL; Genomic and Computational Biology, Duke University Medical Center, Durham, NC, USA., Young CC; Departments of Anesthesiology, Duke University Medical Center, Durham, NC, USA., Ballman KV; Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, NY, USA., Ramakrishna R; Department of Surgery, Weill Cornell Medicine, New York, NY, USA., Cross DA; IMED Oncology, Global Medical Affairs, AstraZeneca, Cambridge, UK., Markert JM; Department of Neurosurgery, The University of Alabama at Birmingham, Birmingham, AL, USA., Lim M; Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Lesser GJ; Department of Internal Medicine, Section on Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA., Kwatra MM; Departments of Anesthesiology, Duke University Medical Center, Durham, NC, USA.; Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA.; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.
Source: Oncotarget [Oncotarget] 2020 Jun 02; Vol. 11 (22), pp. 2074-2082. Date of Electronic Publication: 2020 Jun 02 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32547705
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy of osimertinib against EGFRvIII+ glioblastoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chagoya+G%22">Chagoya G</searchLink>; Department of Neurosurgery, The University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Kwatra+SG%22">Kwatra SG</searchLink>; Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Nanni+CW%22">Nanni CW</searchLink>; Departments of Anesthesiology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Roberts+CM%22">Roberts CM</searchLink>; Departments of Anesthesiology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Phillips+SM%22">Phillips SM</searchLink>; Tri-Institutional MD-PhD Program, Weill Cornell Medical College, The Rockefeller University, Memorial Sloan Kettering Cancer Institute, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Nullmeyergh+S%22">Nullmeyergh S</searchLink>; Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Gilmore+SP%22">Gilmore SP</searchLink>; Departments of Anesthesiology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Spasojevic+I%22">Spasojevic I</searchLink>; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Corcoran+DL%22">Corcoran DL</searchLink>; Genomic and Computational Biology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Young+CC%22">Young CC</searchLink>; Departments of Anesthesiology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Ballman+KV%22">Ballman KV</searchLink>; Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Ramakrishna+R%22">Ramakrishna R</searchLink>; Department of Surgery, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Cross+DA%22">Cross DA</searchLink>; IMED Oncology, Global Medical Affairs, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Markert+JM%22">Markert JM</searchLink>; Department of Neurosurgery, The University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Lim+M%22">Lim M</searchLink>; Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Gilbert+MR%22">Gilbert MR</searchLink>; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Lesser+GJ%22">Lesser GJ</searchLink>; Department of Internal Medicine, Section on Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Kwatra+MM%22">Kwatra MM</searchLink>; Departments of Anesthesiology, Duke University Medical Center, Durham, NC, USA.; Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA.; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101532965%22">Oncotarget</searchLink> [Oncotarget] 2020 Jun 02; Vol. 11 (22), pp. 2074-2082. <i>Date of Electronic Publication: </i>2020 Jun 02 (<i>Print Publication: </i>2020).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Impact+Journals%22">Impact Journals </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101532965 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1949-2553 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219492553%22">19492553 </searchLink><i>NLM ISO Abbreviation: </i>Oncotarget <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32547705
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.18632/oncotarget.27599
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2074
    Titles:
      – TitleFull: Efficacy of osimertinib against EGFRvIII+ glioblastoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chagoya G
      – PersonEntity:
          Name:
            NameFull: Kwatra SG
      – PersonEntity:
          Name:
            NameFull: Nanni CW
      – PersonEntity:
          Name:
            NameFull: Roberts CM
      – PersonEntity:
          Name:
            NameFull: Phillips SM
      – PersonEntity:
          Name:
            NameFull: Nullmeyergh S
      – PersonEntity:
          Name:
            NameFull: Gilmore SP
      – PersonEntity:
          Name:
            NameFull: Spasojevic I
      – PersonEntity:
          Name:
            NameFull: Corcoran DL
      – PersonEntity:
          Name:
            NameFull: Young CC
      – PersonEntity:
          Name:
            NameFull: Ballman KV
      – PersonEntity:
          Name:
            NameFull: Ramakrishna R
      – PersonEntity:
          Name:
            NameFull: Cross DA
      – PersonEntity:
          Name:
            NameFull: Markert JM
      – PersonEntity:
          Name:
            NameFull: Lim M
      – PersonEntity:
          Name:
            NameFull: Gilbert MR
      – PersonEntity:
          Name:
            NameFull: Lesser GJ
      – PersonEntity:
          Name:
            NameFull: Kwatra MM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 06
              Text: 2020 Jun 02
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1949-2553
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 22
          Titles:
            – TitleFull: Oncotarget
              Type: main
ResultId 1